FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to andrology and immunology, and can be used for treating immune male sterility caused by autoimmune reactions on own spermatozoa. That is ensured by the intramuscular introduction of 1 % 3-Oxy-6-methyl-2-ethyl-pyridine hydrochloride 3-5 ml daily 2-3 times a day during a follicular cycle phase of a female partner.
EFFECT: method allows reducing formation and sperm binding of ACAT due to the antioxidant, antihypoxic, angioprotector, antiaggregation effects, and also the action on a histohematogenous barrier function.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING MALE STERILITY CAUSED BY AUTOIMMUNE RESPONSE TO SPERM CELLS | 2012 |
|
RU2517061C1 |
| METHOD OF PHARMACOLOGICAL TREATMENT OF AUTOIMMUNE MALE STERILITY | 1998 |
|
RU2149021C1 |
| METHOD FOR PREDICTION OF MALE REPRODUCTIVE FUNCTION NORMALISATION FOLLOWING VARICOCELECTOMY | 2012 |
|
RU2519185C1 |
| METHOD FOR TREATING AUTOIMMUNE MALE INFERTILITY | 1998 |
|
RU2155596C2 |
| METHOD OF TREATING AUTOIMMUNE MALE STERILITY | 2010 |
|
RU2430725C1 |
| METHOD FOR PREDICTING EJACULATE INFERTILITY IN MEN | 2022 |
|
RU2785487C1 |
| METHOD OF USING EXTRACELLULAR FOLICULAR FLUID VESICLES TO INCREASE HUMAN SPERMATOZOA MOBILITY IN VIRTUE FERTILIZATION PROGRAMS | 2022 |
|
RU2801339C1 |
| METHOD FOR PREDICTING OUTCOMES OF IN VITRO FERTILIZATION | 2022 |
|
RU2776977C1 |
| METHOD OF DETERMINING TREATMENT TACTICS FOR INFERTILITY ASSOCIATED WITH HUMAN PAPILLOMAVIRUS INFECTION IN MEN | 2023 |
|
RU2806807C1 |
| METHOD FOR TREATING AUTOIMMUNE MALE INFERTILITY CASES | 2005 |
|
RU2294779C1 |
